BioIntelliSense, Inc.

A New Era of Continuous Health Monitoring and Clinical Intelligence

[BioIntelliSense, Inc. @biointellisense]

@MethodistHosp study shows BioButton® continuous monitoring cut ICU mortality risk 27% in high-risk patients—catching deterioration hours earlier. Published in Journal of Clinical Medicine. Explore the findings: https://t.co/miJeFs1gWU

[BioIntelliSense, Inc. @biointellisense]

This Sunday is #NationalDoctorsDay!

At BioIntelliSense, we are honored to support the doctors at the intersection of patient care & innovation—and proud to work with them hand-in-hand to enhance patient safety and improve patient outcomes with continuous patient monitoring.

[BioIntelliSense, Inc. @biointellisense]

BioIntelliSense & @HicuityHealth are redefining continuous patient monitoring with a scalable, end-to-end virtual care solution that extends from in-hospital to home.

Learn how our new partnership is helping resolve critical infrastructure & staffing challenges for hospitals:

[BioIntelliSense, Inc. @biointellisense]

At @MethodistHosp, the FDA-cleared BioButton® for continuous patient monitoring is about more than improved workflow – it’s about enabling improved safety and outcomes for patients. Read more in @HealthLeaders: https://t.co/e6oMXc6M0g

[BioIntelliSense, Inc. @biointellisense]

Healthcare can be continuous & effective across care settings. The FDA-cleared BioButton® keeps providers informed & patients at ease, enabling proactive care from in-hospital to home. Lightweight, rechargeable, & trusted by thousands for data-driven care. https://t.co/9782XUenYQ

[BioIntelliSense, Inc. @biointellisense]

#ViVE25 reminded us why we’re passionate about supporting nurses and clinical teams. Thank you for sharing your priorities and challenges—your dedication inspires us.

Missed us at ViVE? Let’s connect: https://t.co/ma59pABO1I

#ViVE2025 #NursingInnovation #BioButtonWearable

[BioIntelliSense, Inc. @biointellisense]

At #ViVE2025, Sarah Pletcher, MD, of @MethodistHosp shares how continuous vitals monitoring using the BioButton® wearable device is enabling more proactive, data-driven care across all nine of their hospitals.

#NursingInnovation #ContinuousMonitoring

[BioIntelliSense, Inc. @biointellisense]

We're proudly partnering with @HicuityHealth to bring 24/7 virtual patient monitoring to U.S. hospitals, easing staffing challenges & clinical burdens. Read more about how we are enhancing patient care w/medical-grade monitoring across settings: https://t.co/PNM9dk29EI

[BioIntelliSense, Inc. @biointellisense]

Headed to #ViVE2025?

Visit us at booth #2438-5 in the Nurse’s Pavilion to learn how the FDA-cleared BioButton® is helping nurses save time, reduce repetitive tasks, and focus on patient care: https://t.co/QEqzsW4xF8

#NursingInnovation #HealthTech

[BioIntelliSense, Inc. @biointellisense]

The BioButton® is transforming healthcare. Join our CEO James Mault, MD, at #ViVE25 on Feb 18, 10:50 am CT, as he discusses “Delivering on the Promise of Wearable Tech” with @rhapsodyhealth.

Learn more: https://t.co/QEqzsW4xF8

#HealthTech #ContinuousMonitoring

[BioIntelliSense, Inc. @biointellisense]

Learn more and schedule a demo here: https://t.co/QEqzsW4xF8

[2/2]

[BioIntelliSense, Inc. @biointellisense]

We’re heading to #ViVE25! Join us in Nashville, Feb 16-19, to see how the BioButton® makes patient monitoring continuous and scalable. Visit booth #2438-5 & don’t miss CEO James Mault, MD's talk, "Delivering on the Promise of Wearable Tech," Feb 18, 10:50am CT. #HealthTech

[1/2]

[BioIntelliSense, Inc. @biointellisense]

The FDA-cleared BioButton® wearable for continuous monitoring helps improve patient outcomes and peace-of-mind for nurses.

In their own words: Hear how the BioButton at @MethodistHosp measures up from nurses on the front lines.

[BioIntelliSense, Inc. @biointellisense]

New peer-reviewed research in the @JCM_MDPI underscores the transformational power of the BioIntelliSense medical-grade BioButton® wearable device and clinical intelligence solution for continuous patient monitoring at scale.

Explore the top findings🔽

[BioIntelliSense, Inc. @biointellisense]

We're proud and honored to be part of this important mission, and to help advance our collective understanding of health here on Earth and now in #space!

[Translational Research Institute for Space Health @BCMSpaceHealth]

🚀 The @BlueOrigin #NS28 crew members participating in #TRISH EXPAND research will wear a @BioIntelliSense BioButton device that monitors and captures personal health and vital signs before, during, and after the mission. Our understanding of #SpaceHealth continues to evolve!

[BioIntelliSense, Inc. @biointellisense]

Mark your calendars! BioIntelliSense CEO James Mault, MD joins the #AHA24 Scientific Sessions panel, “AI Everywhere: Transforming Healthcare from Diagnostics to Virtual Care.”

Sat, Nov 16, 3:55-4:30 PM

#AIinHealthcare #HealthTech #ContinuousMonitoring

[BioIntelliSense, Inc. @biointellisense]

With health systems facing budget and staffing pressures, the FDA-cleared BioButton® Multi-Patient Wearable offers a cost-effective, reliable continuous monitoring solution for general care settings, including Hospital@Home care. Learn more: https://t.co/yANXHYVmk2

[BioIntelliSense, Inc. @biointellisense]

We’re thrilled that @FierceHealth selected the medical-grade BioButton® device as a finalist in the 2024 #FierceInnovationAwards. This honor is a testament to the hard work and ingenuity of the BioIntelliSense team and the incredible nurses on the front lines of patient care.

[BioIntelliSense, Inc. @biointellisense]

“We’re going to look back on this decade as one of the most profound moments in human healthcare.” – BioIntelliSense Founder & CEO Dr. James Mault shared his vision for the future of healthcare at @adghwofficial. Click play for more on the new era in care.

[BioIntelliSense, Inc. @biointellisense]

Register for #DigitalHealthontheHill using this link by September 12th to hear Carolyn showcase the new standard of continuous care during the panel session ‘Screening for Success: ROI of Digital Health Interventions.’ 🔽
https://t.co/fIz4U83pPt
[2/2]

[BioIntelliSense, Inc. @biointellisense]

Next Thursday, BioIntelliSense CCO Carolyn Walsh heads to @EY’s Digital Health on the Hill to meet w/ industry leaders & lawmakers. She’ll share how wireless, multiparameter wearables like the medical-grade BioButton® keep patients connected to care from hospital to home. [1/2]